BriaCell Therapeutics (BCTX) News Today $0.39 +0.02 (+4.23%) As of 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period BriaCell Therapeutics (NASDAQ:BCTX) Shares to Reverse Split on Wednesday, January 29thJanuary 17, 2025 | americanbankingnews.comBriaCell Announces Availability of Annual General Meeting Materials and Alternative Voting ProceduresDecember 17, 2024 | globenewswire.comBriaPro Therapeutics Corp. Announces Availability of Annual General Meeting Materials and Alternative Voting ProceduresDecember 17, 2024 | globenewswire.comBriaCell Therapeutics Announces Closing of $5.5 Million Public OfferingDecember 13, 2024 | globenewswire.comBriaCell 2024 SABCS® Poster Highlights Ability of Bria-IMT™ Regimen to Increase Cancer-Fighting Immune Cells in Metastatic Breast CancerDecember 13, 2024 | globenewswire.comBriaCell Therapeutics (NASDAQ:BCTX) Stock, Short Interest ReportDecember 12, 2024 | benzinga.comWhy BriaCell Therapeutics (BCTX) Stock Is Down 40%December 12, 2024 | benzinga.comBriaCell Therapeutics Announces Pricing of $5.5 Million Public OfferingDecember 11, 2024 | globenewswire.comBriaCell Therapeutics Announces Proposed Public OfferingDecember 11, 2024 | globenewswire.comBriaCell Presents Unprecedented Overall Survival Data in Metastatic Breast Cancer in Spotlight Poster at 2024 SABCS®December 11, 2024 | globenewswire.comBriaCell says DSMB recommends continuation of Phase 3 study in MBCDecember 3, 2024 | markets.businessinsider.comBriaCell Receives Green-Light from Data Safety Monitoring Board for its Phase 3 Study in Metastatic Breast CancerDecember 2, 2024 | globenewswire.comBriaCell to highlight OS, clinical benefit data of Bria-IMT in MBC patientsNovember 26, 2024 | markets.businessinsider.comBriaCell 2024 SABCS® Spotlight Poster to Showcase Positive Overall Survival Data Across All Patient Subtypes in Metastatic Breast CancerNovember 26, 2024 | globenewswire.comBriaCell Provides Update to its Board of DirectorsNovember 25, 2024 | globenewswire.comBriaCell announces first patient dosed with Bria-OTS in Phase 1/2 studyNovember 22, 2024 | markets.businessinsider.comBriaCell Therapeutics Corp.: BriaCell Announces First Patient Dosed with Bria-OTS in Metastatic Breast Cancer StudyNovember 21, 2024 | finanznachrichten.deBriaCell Announces First Patient Dosed with Bria-OTS™ in Metastatic Breast Cancer StudyNovember 21, 2024 | globenewswire.comBriaCell reports preclinical data of personalized off-the-shelf immunotherapiesNovember 9, 2024 | markets.businessinsider.comBriaCell Showcases Robust Anti-Cancer Activity of Personalized Off-the-Shelf Immunotherapy Pipeline at the 2024 SITC ConferenceNovember 8, 2024 | globenewswire.comBriaCell Overall Survival Data Selected for Spotlight Poster at 2024 San Antonio Breast Cancer Symposium®, December 10 – 13November 4, 2024 | globenewswire.comBriaCell announces survival data from Phase 2 metastatic breast cancer studyOctober 22, 2024 | markets.businessinsider.comBriaCell Reports Outperforming Metastatic Breast Cancer Patients and Standard-Beating Survival DataOctober 22, 2024 | globenewswire.comBriaCell Provides Phase 3 Clinical Engagement Update in Metastatic Breast Cancer Pivotal StudyOctober 15, 2024 | globenewswire.comBriaCell Therapeutics Announces Closing of $5 Million OfferingOctober 2, 2024 | globenewswire.comBriaCell Therapeutics Announces $5 Million OfferingOctober 1, 2024 | globenewswire.comBriaCell dips despite promising mid-stage data for breast cancer therapyOctober 1, 2024 | seekingalpha.comBriaCell Reports 100% Resolution of Brain Metastasis in Breast Cancer Patient with “Eye-Bulging” TumorOctober 1, 2024 | globenewswire.comBriaCell Announces FDA-Authorized Expanded Access Policy for Metastatic Breast Cancer PatientsSeptember 18, 2024 | globenewswire.comBriaCell Therapeutics Announces Closing of $8.5 Million OfferingSeptember 12, 2024 | globenewswire.comBriaCell Therapeutics Shares Retreat From Earlier Surge After Stock OfferingSeptember 11, 2024 | marketwatch.comBriaCell Therapeutics Announces $8.5 Million OfferingSeptember 11, 2024 | globenewswire.comWhy Is Breast Cancer-Focused BriaCell Therapeutics Stock Trading Over 100% On WednesdaySeptember 11, 2024 | benzinga.comBriaCell Reports Positive Overall Survival (OS) in Metastatic Breast CancerSeptember 11, 2024 | globenewswire.comBriaCell Announces Positive Pre-IND Meeting with FDA for Bria-PROS+™ for Prostate CancerSeptember 10, 2024 | globenewswire.comBriaCell Announces Presentation at the 2024 Society for Immunotherapy of Cancer (SITC) Annual MeetingSeptember 9, 2024 | globenewswire.comBriacell Therapeutics Corp (BCT)August 15, 2024 | investing.comBriaCell Quadruples Progression Free Survival (PFS) in Patient with “Eye-Bulging” Metastatic Breast CancerJuly 18, 2024 | globenewswire.comBriaCell Presents Clinical Efficacy Data at ASCO 2024June 3, 2024 | globenewswire.comBriaCell Doubles Progression-Free-Survival (PFS) and Reports Clinical Benefit Data at ASCO 2024May 24, 2024 | globenewswire.comBriaCell Therapeutics Announces Closing of $5.0 Million Registered Direct OfferingMay 17, 2024 | globenewswire.comBriaCell Therapeutics Announces Pricing of $5.0 Million Registered Direct OfferingMay 15, 2024 | globenewswire.comBriaCell Announces Oral and Poster Presentations at ASCO 2024April 24, 2024 | globenewswire.comBriaCell 2024 AACR Preclinical Poster Confirms Strong Anti-Cancer Activity of Bria-OTS+™ and Bria-PROS+™ Clinical Candidates for Breast and Prostate CancerApril 10, 2024 | globenewswire.comBriaCell Showcases Data Demonstrating Unmatched Progression-Free Survival (PFS) and Clinical Efficacy in Antibody-Drug Conjugate (ADC) Resistant and Central Nervous System (CNS) Metastatic Breast Cancer at the 2024 AACRApril 9, 2024 | finance.yahoo.comBriaCell Therapeutics Corp. (BCTX)March 20, 2024 | sg.finance.yahoo.comBriaCell Receives and Executes Letter of Intent to Advance Clinical Development of Breast and Prostate Cancer ImmunotherapiesMarch 7, 2024 | globenewswire.comBriaCell to Present Clinical Data in Central Nervous System (CNS) Metastasis and Antibody-Drug Conjugate (ADC) Resistant Breast Cancer at the 2024 AACR ConferenceMarch 6, 2024 | globenewswire.comBriaCell Provides Update on Alleged Illegal Trading of Public SecuritiesFebruary 27, 2024 | finance.yahoo.comBriaCell Provides Update on Alleged Illegal Trading of Public SecuritiesFebruary 27, 2024 | globenewswire.com Get BriaCell Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BCTX and its competitors with MarketBeat's FREE daily newsletter. Email Address BCTX Media Mentions By Week BCTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BCTX News Sentiment▼0.670.63▲Average Medical News Sentiment BCTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BCTX Articles This Week▼11▲BCTX Articles Average Week Get BriaCell Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BCTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies CTMX News UNCY News OPTN News OSTX News GBIO News ONCY News IMRX News FBLG News GANX News KRON News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BCTX) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BriaCell Therapeutics Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share BriaCell Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BCTX Stock Alerts